Commission Implementing Regulation (EU) 2026/372 of 20 February 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1-naphthylacetamide, 1-naphthylacetic acid, 6-benzyladenine, aluminium sulfate, boscalid, dodine, esfenvalerate, eugenol, fenpyroximate, fluazifop-P, fluazinam, fluometuron, fluopyram, flutolanil, geraniol, malathion, penoxsulam, pinoxaden, prohexadione, proquinazid, prosulfuron, pyrethrins, pyridaben, pyrimethanil, sintofen, spiroxamine, sulphur and thymol
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
134/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2026/372 of 20 February 2026 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1-naphthylacetamide, 1-naphthylacetic acid, 6-benzyladenine, aluminium sulfate, boscalid, dodine, esfenvalerate, eugenol, fenpyroximate, fluazifop-P, fluazinam, fluometuron, fluopyram, flutolanil, geraniol, malathion, penoxsulam, pinoxaden, prohexadione, proquinazid, prosulfuron, pyrethrins, pyridaben, pyrimethanil, sintofen, spiroxamine, sulphur and thymol
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2026/372 frá 20. febrúar 2026 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilunum fyrir virku efnin 1-dekanól, 1-naftýlasetamíð, 1-naftýlediksýru, 6-bensýladenín, álsúlfat, boskalíð, dódín, esfenvalerat, evgenól, fenpýroxímat, flúasífóp-P, flúasínam, flúómetúrón, flúópýram, flútólaníl, geraníól, malaþíón, penoxsúlam, pínoxaden, próhexadíón, prókínasíð, prósúlfúrón, pýretrín, pýridaben, pýrimetaníl, sintófen, spíroxamín, brennistein og þýmól
Durchführungsverordnung (EU) 2026/372 der Kommission vom 20. Februar 2026 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigung für die Wirkstoffe 1-Decanol, 1-Naphthylacetamid, 1-Naphthylessigsäure, 6-Benzyladenin, Aluminiumsulfat, Boscalid, Dodin, Esfenvalerat, Eugenol, Fenpyroximat, Fluazifop-P, Fluazinam, Fluometuron, Fluopyram, Flutolanil, Geraniol, Malathion, Penoxsulam, Pinoxaden, Prohexadion, Proquinazid, Prosulfuron, Pyrethrine, Pyridaben, Pyrimethanil, Sintofen, Spiroxamin, Schwefel und Thymol
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.